Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMO | O15229 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19455822 | 0.82 | ADRB1 (0.35) | KMO | |
| SCHEMBL19455749 | 0.78 | — | — | |
| SCHEMBL31413728 | 0.65 | KMO (0.53) | KMO | |
| SCHEMBL7697488 | 0.65 | KMO (0.53) | KMO | |
| SCHEMBL24087665 | 0.63 | KMO (0.37) | KMO | |
| SCHEMBL21328933 | 0.60 | MALT1 (0.52) | — | |
| SCHEMBL17049133 | 0.59 | — | — | |
| SCHEMBL27725996 | 0.59 | — | — | |
| SCHEMBL138862 | 0.58 | — | — | |
| SCHEMBL29607 | 0.56 | ADRB1 (0.38) | KMO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170294606-A1 | Iridium complex, method for manufacturing same, and organic light-emitting devices using same | AAC Technologies Pte. Ltd. (SG) | 2017-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170294606-A1 | Iridium complex, method for manufacturing same, and organic light-emitting devices using same | ODC1, ORC3, DDC | KMO 887/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.